BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 14678277)

  • 21. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis.
    Invernizzi P; Crosignani A; Battezzati PM; Covini G; De Valle G; Larghi A; Zuin M; Podda M
    Hepatology; 1997 May; 25(5):1090-5. PubMed ID: 9141422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis.
    Zhang FK; Jia JD; Wang BE
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):288-91. PubMed ID: 15138128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis.
    Liu H; Norman GL; Shums Z; Worman HJ; Krawitt EL; Bizzaro N; Vergani D; Bogdanos DP; Dalekos GN; Milkiewicz P; Czaja AJ; Heathcote EJ; Hirschfield GM; Tan EM; Miyachi K; Bignotto M; Battezzati PM; Lleo A; Leung PS; Podda M; Gershwin ME; Invernizzi P
    J Autoimmun; 2010 Dec; 35(4):436-42. PubMed ID: 20932720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome.
    Muratori P; Granito A; Pappas G; Pendino GM; Quarneti C; Cicola R; Menichella R; Ferri S; Cassani F; Bianchi FB; Lenzi M; Muratori L
    Am J Gastroenterol; 2009 Jun; 104(6):1420-5. PubMed ID: 19491855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High sensitivity of a novel ELISA for anti-M2 in primary biliary cirrhosis.
    Miyakawa H; Kikuchi K; Jong-Hon K; Kawaguchi N; Yajima R; Ito Y; Maekubo H
    J Gastroenterol; 2001 Jan; 36(1):33-8. PubMed ID: 11211208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients.
    Zografos TA; Gatselis N; Zachou K; Liaskos C; Gabeta S; Koukoulis GK; Dalekos GN
    World J Gastroenterol; 2012 Sep; 18(34):4721-8. PubMed ID: 23002341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similar clinical outcome of AMA immunoblot-M2-negative compared to immunoblot-positive subjects over six years of follow-up.
    Zandanell S; Strasser M; Feldman A; Strebinger G; Aigner G; Niederseer D; Laimer M; Mussnig B; Paulweber B; Datz C; Aigner E
    Postgrad Med; 2021 Apr; 133(3):291-298. PubMed ID: 33538618
    [No Abstract]   [Full Text] [Related]  

  • 28. A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis.
    Oertelt S; Rieger R; Selmi C; Invernizzi P; Ansari AA; Coppel RL; Podda M; Leung PS; Gershwin ME
    Hepatology; 2007 Mar; 45(3):659-65. PubMed ID: 17326160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities.
    Parveen S; Morshed SA; Nishioka M
    J Gastroenterol Hepatol; 1995; 10(4):438-45. PubMed ID: 8527711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary biliary cirrhosis--presentation and diagnosis.
    Leuschner U
    Clin Liver Dis; 2003 Nov; 7(4):741-58. PubMed ID: 14594129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity of antimitochondrial antibodies with the M2-M4 pattern by immunofluorescence as assessed by Western immunoblotting and enzyme linked immunosorbent assay.
    Fusconi M; Ghadiminejad I; Bianchi FB; Baum H; Bottazzo GF; Pisi E
    Gut; 1988 Apr; 29(4):440-7. PubMed ID: 2453397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of novel non-M2-related antimitochondrial antibodies in patients with anti-M2 negative primary biliary cirrhosis.
    Feuchtinger M; Christ S; Preuss B; Dengjel J; Duman S; Stevanovic S; Klein R
    Gut; 2009 Jul; 58(7):983-9. PubMed ID: 19336422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis according to antimitochondrial antibodies status.
    Alric L; Thebault S; Selves J; Peron JM; Mejdoubi S; Fortenfant F; Vinel JP
    Gastroenterol Clin Biol; 2007 Jan; 31(1):11-6. PubMed ID: 17273127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimitochondrial antibody detection by indirect immunofluorescence on mouse sperms.
    Martínez S; Berríos S; Fernandez-Donoso R; Brahm J; Cuchacovich M
    Eur J Histochem; 1996; 40(4):315-22. PubMed ID: 9116339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does the diagnosis of primary biliary cirrhosis or autoimmune cholangitis depend on the 'phase' of the disease?
    Kadokawa Y; Omagari K; Ohba K; Masuda J; Hazama H; Kinoshita H; Ohnita K; Mizuta Y; Tanioka H; Imanishi T; Kohno S
    Liver Int; 2005 Apr; 25(2):317-24. PubMed ID: 15780056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantigens in primary biliary cirrhosis.
    Jones DE
    J Clin Pathol; 2000 Nov; 53(11):813-21. PubMed ID: 11127262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies by line immunoassay in patients with primary biliary cirrhosis.
    Saito H; Takahashi A; Abe K; Okai K; Katsushima F; Monoe K; Kanno Y; Ohira H
    Fukushima J Med Sci; 2012; 58(2):107-16. PubMed ID: 23237866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease.
    Milkiewicz P; Buwaneswaran H; Coltescu C; Shums Z; Norman GL; Heathcote EJ
    Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1355-60. PubMed ID: 19631286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of autoimmune liver disease related autoantibodies in Chinese patients with primary biliary cirrhosis.
    Hu C; Deng C; Song G; Zhang W; Zhang S; Li X; Li P; Zhang F; Li Y
    Dig Dis Sci; 2011 Nov; 56(11):3357-63. PubMed ID: 21660486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a lipoyl domain-independent B-cell autoepitope on the human branched-chain acyltransferase in primary biliary cirrhosis and overlap syndrome with autoimmune hepatitis.
    Csepregi A; Obermayer-Straub P; Kneip S; Kayser A; Loges S; Schmidt E; Nemesánszky E; Szalay F; Manns MP; Strassburg CP
    Clin Dev Immunol; 2003; 10(2-4):173-81. PubMed ID: 14768949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.